Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 715

1.

Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study.

Friedman DM, Kim MY, Copel JA, Davis C, Phoon CK, Glickstein JS, Buyon JP; PRIDE Investigators.

Circulation. 2008 Jan 29;117(4):485-93. doi: 10.1161/CIRCULATIONAHA.107.707661. Epub 2008 Jan 14.

2.

Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.

Mevorach D, Elchalal U, Rein AJ.

Curr Opin Rheumatol. 2009 Sep;21(5):478-82. doi: 10.1097/BOR.0b013e32832ed817. Review.

PMID:
19584727
4.

Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.

Skog A, Wahren-Herlenius M, Sundström B, Bremme K, Sonesson SE.

Pediatrics. 2008 Apr;121(4):e803-9. doi: 10.1542/peds.2007-1659.

PMID:
18381509
5.

Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study.

Gerosa M, Cimaz R, Stramba-Badiale M, Goulene K, Meregalli E, Trespidi L, Acaia B, Cattaneo R, Tincani A, Motta M, Doria A, Zulian F, Milanesi O, Brucato A, Riboldi P, Meroni PL.

Rheumatology (Oxford). 2007 Aug;46(8):1285-9. Epub 2007 Apr 20.

PMID:
17449486
6.

Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective.

Friedman DM, Rupel A, Glickstein J, Buyon JP.

Indian J Pediatr. 2002 Jun;69(6):517-22. Review.

PMID:
12139139
7.

Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.

Chang YL, Hsieh PC, Chang SD, Chao AS, Liang CC, Soong YK.

Eur J Obstet Gynecol Reprod Biol. 2005 Oct 1;122(2):167-71.

PMID:
16219517
8.

Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.

Clancy RM, Buyon JP, Ikeda K, Nozawa K, Argyle DA, Friedman DM, Chan EK.

Arthritis Rheum. 2005 Oct;52(10):3079-86.

9.

Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study.

Pisoni CN, Brucato A, Ruffatti A, Espinosa G, Cervera R, Belmonte-Serrano M, Sánchez-Román J, García-Hernández FG, Tincani A, Bertero MT, Doria A, Hughes GR, Khamashta MA.

Arthritis Rheum. 2010 Apr;62(4):1147-52. doi: 10.1002/art.27350.

10.

Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group.

Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM, Huong DL, Denjoy I, Vauthier D, Sebbouh D, Fain O, Georgin-Lavialle S, Ghillani P, Musset L, Wechsler B, Duhaut P, Piette JC.

Arthritis Rheum. 2004 Oct;50(10):3187-94.

11.

Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options.

Costedoat-Chalumeau N, Amoura Z, Villain E, Cohen L, Piette JC.

Arthritis Res Ther. 2005;7(2):69-73. Epub 2005 Jan 25. Review.

12.

Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women.

Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, Muscarà M, Vignati G, Stramba-Badiale M, Catelli L, Lojacono A, Cavazzana I, Ghirardello A, Vescovi F, Gambari PF, Doria A, Meroni PL, Tincani A.

Arthritis Rheum. 2001 Aug;44(8):1832-5.

13.

Congenital heart block: clinical features and therapeutic approaches.

Gordon PA.

Lupus. 2007;16(8):642-6. Review.

PMID:
17711901
14.

Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies.

Sonesson SE, Salomonsson S, Jacobsson LA, Bremme K, Wahren-Herlenius M.

Arthritis Rheum. 2004 Apr;50(4):1253-61.

15.

Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies.

Askanase AD, Friedman DM, Copel J, Dische MR, Dubin A, Starc TJ, Katholi MC, Buyon JP.

Lupus. 2002;11(3):145-51.

PMID:
11999879
16.

[Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].

Ayed K, Gorgi Y, Sfar I, Khrouf M.

Pathol Biol (Paris). 2004 Apr;52(3):138-47. Review. French.

PMID:
15063933
17.

[Intrauterine therapy and outcome in four pregnancies of one mother with anti ro-autoantibody positive Sjoegren's syndrome].

Zemlin M, Bauer K, Dörner T, Altinöz H, Versmold H.

Z Geburtshilfe Neonatol. 2002 Jan-Feb;206(1):22-5. German.

PMID:
11887252
18.

Atrioventricular conduction in children of women with systemic lupus erythematosus.

Goble MM, Dick M 2nd, McCune WJ, Ellsworth J, Sullivan DB, Stern AM.

Am J Cardiol. 1993 Jan 1;71(1):94-8.

19.

Autoantibody-associated congenital heart block: outcome in mothers and children.

Waltuck J, Buyon JP.

Ann Intern Med. 1994 Apr 1;120(7):544-51.

PMID:
8116991
20.

Prevention of congenital heart block in children of SSA-positive mothers.

Brucato A.

Rheumatology (Oxford). 2008 Jun;47 Suppl 3:iii35-7. doi: 10.1093/rheumatology/ken153. Review.

PMID:
18504284

Supplemental Content

Support Center